SSStefan Rudolf Bertram Schneider

Stefan Rudolf Bertram Schneider

*This is an algorithmically generated author record based on publicly available information.

Stefan Rudolf Bertram Schneider has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Hh Scheld

    6 shared publications
  • Sven Martens

    Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University Hospital of the Westfaelische Wilhelms-University Muenster, Albert-Schweitzer-Campus 1, 48159, Muenster, Germany

    6 shared publications
  • Andreas Rukosujew

    Department of Cardiothoracic Surgery, University Hospital Muenster, 48149 Muenster, Germany

    5 shared publications
  • Jürgen R. Sindermann

    Department of Cardiac Surgery, University Hospital Münster, Münster, Germany

    5 shared publications
  • Dominik Schlarb

    Division of Cardiac Surgery, Department of Cardiothoracic Surgery, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Germany

    4 shared publications
  • Andreas Hoffmeier

    University Hospital Muenster, Department of Cardiac Surgery, Muenster, Germany

    3 shared publications

Latest Publications

  • Early outcomes in re-do operation after acute type A aortic dissection: results from the multicenter REAAD database

    by Angelo M. Dell’aQuila, Francesco Pollari, Khalil Fattouch, Giuseppe Santarpino, Julia Hillebrand, Stefan Schneider, Jan Landwerht, Giuseppe Nasso, Renato Gregorini, Mauro del Giglio, et al.

    This study provides early results of re-operations after the prior surgical treatment of acute type A aortic dissection (AAD) and identifies risk factors for mortality. Between May 2003 and January 2014, 117 aortic re-operations after an initial operation for AAD (a mean time from the first procedure was 3.98 years, with a range of 0.1–20.87 years) were performed in 110 patients (a mean age of 59.8 ± 12.6 years) in seven European institutions. The re-operation was indicated due to a proximal aortic pathology in ninety cases: twenty aortic root aneurysms, seventeen root re-dissections, twenty-seven aortic valve insufficiencies and twenty-six proximal anastomotic pseudoaneurysms. In fifty-eight cases, repetitive surgical treatment was subscripted because of distal aortic pathology: eighteen arch re-dissections, fifteen arch dilation and twenty-five anastomotic pseudoaneurysms. Surgical procedures comprised a total of seventy-one isolated proximals, thirty-one isolated distals and fifteen combined interventions. In-hospital mortality was 19.6 % (twenty-three patients); 11.1 % in patients with elective/urgent indication and 66.6 % in emergency cases. Mortality rates for isolated proximal, distal and combined operations regardless of the emergency setting were 14.1 % (10 pts.), 25.8 % (8 pts.) and 33.3 % (5 pts.), respectively. The causes of death were cardiac in eight, neurological in three, MOF in five, sepsis in two, bleeding in three and lung failure in two patients. A multivariate logistic regression analysis revealed that risk factors for mortality included previous distal procedure (p = 0.04), new distal procedure (p = 0.018) and emergency operation (p < 0.001). New proximal procedures were not found to be risk factors for early mortality (p = 0.15). This multicenter experience shows that the outcome of REAAD is highly dependent on the localization and extension of aortic pathology and the need for emergency treatment. Surgery in an emergency setting and distal re-do operations after previous AAD remain a surgical challenge, while proximal aortic re-operations show a lower mortality rate. Foresighted decision-making is needed in cases of AAD repair, as the results are essential preconditions for further surgical interventions.


  • Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device

    by Angelo Maria Dell’aQuila, Stefano Mastrobuoni, Sebastian Alles, Christian Wenning, Welp Henryk, Stefan Rudolf Bertram Schneider, Heinz Deschka, Jürgen R. Sindermann, Mirela Scherer


  • Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors

    by Angelo Maria Dell'AQuila, Stefan R.B. Schneider, Paolo Risso, Henryk Welp, David G. Glockner, Sebastian Alles, Jürgen R. Sindermann, Mirela Scherer

    Poor survival has been demonstrated after ventricular assist device (VAD) implantation for Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile 1 and 2 patients compared with more stable levels. However, risk factors within this high‐risk cohort have not been determined so far. The aim of the present study was to identify risk factors associated with this very high mortality rate. Between February 1993 and January 2013, 298 patients underwent VAD implantation in our institution. One hundred nine patients were in INTERMACS level 1 and 49 patients were in INTERMACS level 2 and were therefore defined as hemodynamically critical (overall 158 patients). Assist devices implanted were: HVAD HeartWare n = 18; Incor n = 11; VentrAssist n = 2; DeBakey n = 22; and pulsatile systems n = 105. After cumulative support duration of 815.35 months, Kaplan–Meier analysis revealed a survival of 63.9, 48.8, and 40.3% at 1, 6, and 12 months, respectively. Cox regression analyses identified age > 50 (P = 0.001, odds ratio [OR] 2.48), white blood cell count > 13.000/μL (P = 0.01, OR 2.06), preoperative renal replacement therapy (P = 0.001, OR 2.63), and postcardiotomy failure (P < 0.001, OR 2.79) as independent predictors of mortality. Of note, last generation VADs were not associated with significantly better 6‐month survival (P = 0.59). Patients without the aforementioned risk factors could yield a survival of 79.2% at 6 months. This single‐center experience shows that VAD implantation in hemodynamically unstable patients generally results in poor early outcome, even in third‐generation pumps. However, avoiding the aforementioned risk factors could result in improved outcome.


  • Severe Hemolysis after Paravalvular Leak Closure of a Mitral Prosthesis with an Amplatzer Device

    by S. Schneider, A. M. Dell'Aquila, H. Deschka, S. Martens, A. Rukosujew

    Introduction: Paravalvular leak after valve replacement is a well-known complication, that besides its hemodynamic effects may as well lead to haemolysis. Interventional closure of paravalvular leaks with special devices has widely been reported. It is especially useful in high-risk patients. The possible complications include the failure to position the device and incomplete closure of the leak. In the pediatric patient population haemolysis has been reported as a complication after positioning of closure devices for congenital heart defects. Background: We report the case of a 78-year-old woman who had undergone biological mitral valve replacement in 2013. At the time of surgery severe calcification oft he annulus was present. Nevertheless MVR was successful until the patient developed paravalvular leakage in spring 2014 without any signs of endocarditis but with symptoms of chronic heart failure. In an interdisciplinary consent we decided to implant an amplatzer device for closure of the paravalvular leak to avoid re-do surgery for the multi morbid patient. The intervention was performed with good success, echocardiography showed only minimal paravalvular insufficiency. Unfortunately the patient developed severe haemolysis shortly after. Transfusion requirements reached up to two packed red blood cell units per week. Now re-do surgery was inevitable. For re-do surgery we used standardized surgical access. The roof of the left atrium was incised to gain access to the mitral valve. The amplatzer device was found closing the leak in the posterior mitral annulus (Fig. 1). We were able to gently pull it out. The leak was then covered with a plication of the enlarged left atrium that was sutured to the sewing ring of the mitral prosthesis. With this procedure we were able to avoid complete decalcification of the annulus and a change of the biological mitral prosthesis, which would have been surgically demanding and risky for our patient. Intraoperative ultrasound of the heart showed that there was no paravalvular leak left. The further postoperative course was uneventful. Discussion: In our case haemolysis did not occur as a result of the paravalvular leak as it is mostly described, but as a complication after closure of the defect with the amplatzer device. In the attempt to minimize the risks for our patients we sometimes tend to overestimate the risks of surgical procedures and underestimate the risks of the interventional procedures.

  • Results of “elephant trunk” total aortic arch replacement using a multi-branched, collared graft prosthesis

    by Stefan R.B. Schneider, Angelo M. Dell’aQuila, Ali Akil, Dominik Schlarb, Guiseppe Panuccio, Sven Martens, Andreas Rukosujew

    We report on our experience with a simplified elephant trunk (ET) procedure with a multi-branched prosthesis (Vascutek® Siena™ Collared Graft). It consists of a proximal portion (20 cm) with prefabricated side branches, a collar and a distal portion (30 cm). The collar, which can be trimmed into any desired diameter, constitutes the suture portion to the descending aorta. Radiopaque markers in the distal portion indicate the landing zone. Between January 2011 and June 2013, 20 consecutive patients (10 women; mean age, 66 ± 9.3 years) underwent ET procedure, including 6 re-do cases. Underlying aortic diseases were acute dissection (n = 6), chronic dissection (n = 4), aneurysm (n = 8) and PAU (n = 2). Mean preoperative diameter of the descending aorta was 49.1 ± 12.9 mm (range 74.7–29.7 mm). Concomitant procedures included ascending aortic replacement in 16 patients; root replacement in 2; AVR in 2, CABG in 3 and mitral repair in 1 patient. CPB time was 263 ± 94 min; mean duration of ACP was 65 ± 14 min. Two patients died on POD 8 and 78, respectively. Major adverse events included stroke (n = 1), resternotomy for bleeding (n = 2), renal failure requiring temporary dialysis (n = 1) and recurrent nerve paresis (n = 2). After a mean follow-up of 10 ± 8 months, all discharged patients were alive. Seven patients underwent stent-graft implantation of the descending aorta and one patient underwent open descending aortic replacement. The last generation of multi-branched arch prosthesis and especially the Vascutek® Siena™ Collared Graft make ET procedure a reasonable treatment option even in patients with acute aortic dissection.


  • Open Access

    Biatrial Recurrence of Two Independently Growing Cardiac Myxoma in a Patient with Multiple Tumor Disease

    by Angelo Dell'Aquila, Sven Martens, Andreas Rukosujew, Stefan R.B. Schneider

    We report the case of a 56-year-old female patient with biatrial recurrence of cardiac myxoma and extensive comorbidities. In the literature, only few cases of biatrial myxoma can be found and they generally describe a single tumor reaching both atria. We found two independently growing cardiac myxomas of both atria.


  • Survival Results After Implantation of Intrapericardial Third-Generation Centrifugal Assist Device: An INTERMACS-Matched Comparison Analysis

    by Angelo M. Dell'Aquila, Stefan R.B. Schneider, Jörg Stypmann, Björn Ellger, Bassam Redwan, Dominik Schlarb, Sven Martens, Jürgen R. Sindermann


  • Unexpected Screening Finding: Aortic Aneurysm in a 25-Year-Old Woman

    by Dominik Schlarb, Angelo M. Dell'Aquila, Stefan Schneider, Tonny D.T. Tjan, Sven Martens, Andreas Hoffmeier

  • Does coronary disease increase the hospital lethality in patients with aortic valve disease undergoing valve replacement?

    by Ha Welp, A Ruhroth, Hh Scheld, S Martens, M Scherer, Am Dell'Aquila, Srb Schneider, Tdt Tjan, A Hoffmeier

    Objectives: With the increase in life expectancy occurred in recent decades, a concomitant increase in the prevalence of aortic stenosis and coronary artery disease (CAD) has been noted. This study aims to evaluate the influence of CAD in patients undergoing isolated aortic valve replacement (AVR). Methods: In the period from January 2007 to 2011, we retrospectively analyzed 94 patients undergoing isolated AVR with concomitant CAD (group I) and 314 patients undergoing isolated AVR without CAD (group II). Patients with endocarditis and/or combined intervention were excluded. The statistical study employed univariant and multivariate analysis. Results: In hospital mortality was 4.0% in group I and 5.0% in group II. In group I significantly more patients developed renal failure (21.0% vs. 8.0%; OR: 3.13; p = 0.0) as well as acute myocardial infarction (4.0% vs. 0.3%; OR: 13.88; p = 0.019) during their hospital stay. No statistical significant difference between both groups was observed concerning the stroke rate (1.0% vs. 5.0%; OR: 0.21; p = 0.138). However patients in group I suffered significantly more often from postoperative psychotic syndromes (40.0% vs. 26.0%; OR: 1.92; p = 0.008). Conclusions: Our results suggest that AVR is a treatment with excellent surgical results even in the presence of concomitant CAD. Despite a higher risk in patients with concomitant CAD for perioperative development of renal failure, postoperative psychotic symptoms and acute myocardial infarction, the presence of CAD has no significant influence on in hospital lethality.

  • Initial Clinical Experience With the HeartWare Left Ventricular Assist System: A Single-Center Report

    by Angelo Maria Dell'Aquila, Stefan Rudolf Bertram Schneider, Dominik Schlarb, Bassam Redwan, Jürgen R. Sindermann, Björn Ellger, Jörg Stypmann, Tony D.T. Tjan, Hans H. Scheld, Andreas Hoffmeier